ATEZOLIZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
11930XMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 5 $9536.43 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
11931YMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 3 $9536.43 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
11940KMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 3 $9713.34 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
11957HMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 5 $9713.34 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
12076NMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 3 $9713.34 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
12078QMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 3 $9536.43 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
12097QMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 5 $9536.43 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
12098RMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 5 $9713.34 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
12159YMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 5 $9713.34 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
12174RMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 5 $9536.43 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
13170EMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 5 $9713.34 $31.60 $31.60
space

ATEZOLIZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
13173HMP ATEZOLIZUMAB
Injection (PI, CMI)
Available brands
Tecentriq
(atezolizumab 840 mg/14 mL injection, 14 mL vial)
1680 mg 5 $9536.43 $31.60 $31.60
space


  • Legend
  • MPMedical Practitioner